Iovance Biotherapeutics
IOVA
#3883
Rank
HK$25.02 B
Marketcap
HK$54.09
Share price
-5.61%
Change (1 day)
210.27%
Change (1 year)

EPS for Iovance Biotherapeutics (IOVA)

EPS in 2026 (TTM): -HK$4.14

According to Iovance Biotherapeutics 's latest financial reports the company's current EPS (TTM) is -HK$4.15. In 2025 the company made an earnings per share (EPS) of -HK$8.78 an increase over its 2024 EPS that were of -HK$10.19.

EPS history for Iovance Biotherapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$4.14-52.79%
2025-HK$8.78-13.85%
2024-HK$10.19
2022-HK$19.4411.71%
2021-HK$17.40
2019-HK$12.3823.44%
2018-HK$10.03-9.22%
2017-HK$11.05-20.34%
2016-HK$13.87176.56%
2015-HK$5.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-HK$0.47-88.68% Bahamas
NRC Health
NRC
HK$2.27-154.72%๐Ÿ‡บ๐Ÿ‡ธ USA